Adam Skinner and colleagues used dynamic Bayesian network analysis to infer the complex causal networks that link social determinants to mental health in a nationally representative sample, consisting of around 25,000 participants in the Household, Income and Labour Dynamics in Australia (HILDA) Survey. 

As the world prepares for the final round of negotiations on a legally binding global plastics treaty (INC-5.2), from 5-14 August 2025, over 60 academic experts have stepped forward to outline exactly what they believe the treaty must include, and why this moment is a potential turning point in environmental policy.

You are invited to a briefing event hosted by the journal Cambridge Prisms: Plastics, which is published by Cambridge University Press. The confirmed speakers are Professor Maria Ivanova, Professor Max Liboiron, Professor Cressida Bowyer, Professor Tony Walker, and Professor Susanne Brander.

Date: 24 July 2025

Time: 2 pm (BST) / 9 am (EDT)

Platform: Zoom

Access Link: https://cup.org/4kJTxWn

Nearly half of drug-caused deaths by healthcare workers involved drugs that were obtained from their place of work, new research finds.

A study by investigators at the Icahn School of Medicine at Mount Sinai, in collaboration with colleagues from Rabin Medical Center in Israel and other collaborators, suggests that even the most advanced artificial intelligence (AI) models can make surprisingly simple mistakes when faced with complex medical ethics scenarios. The findings, which raise important questions about how and when to rely on large language models (LLMs), such as ChatGPT, in health care settings, were reported in the July 22 online issue of NPJ Digital Medicine. 

An antibody developed at Stanford Medicine can prepare patients for stem cell transplantation, sparing them toxic side effects, a phase 1 clinical trial found.

By sparking the immune system into action, radiation therapy makes certain tumors that resist immunotherapy susceptible to the treatment, leading to positive outcomes for patients, according to new research by investigators at the Johns Hopkins Kimmel Cancer Center Bloomberg~Kimmel Institute for Cancer Immunotherapy and the Netherlands Cancer Institute. The work was supported by the National Institutes of Health.